Craig Tendler, M.D. is Vice President and Global Head of Clinical Development, Diagnostics, and Medical Affairs for the Oncology Therapeutic Area at Janssen Research & Development, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. In this position, he [...]

Sean Khozin, MD, MPH, a physician-executive, board-certified oncologist, and data scientist with over 15 years of experience in therapeutic development, drug regulation, and the applications of artificial intelligence and machine learning in biomedical research. As the founder of Phyusion, Dr. [...]

Emily Morris-McCarthy is the general manager, head U.S. oncology for Sanofi. She previously served as franchise head for alliance/immuno-oncology and senior director of marketing for U.S. immuno-oncology marketing at Sanofi. Before coming to Sanofi, she was senior director of U.S. [...]

Dr. Peter Sandor has 25 years of biopharmaceutical leadership experience and currently serves as the senior vice president, Primary Focus Lead, Primary Focus Immuno-oncology at Astellas.In his role, Dr. Sandor has responsibility for leading the strategic direction of Astellas’ early [...]

Tara Frenkl, MD, MPH is the Head of Oncology Development at Bayer's Oncology Strategic Business Unit. Prior to joining Bayer, she held the role of Senior Vice President, Head of Medicine Development Leaders in Oncology at GlaxoSmithKline, with strategic impact on [...]

Stu Bailey is senior vice president, head of clinical measurement sciences at EMD Serono, Inc.. He previously served as vice president, head of analytics and data sciences at Biogen and global head of early development biostatistics at Novartis Institutes for [...]

Brian Alexander, MD, was named Chief Executive Officer of Foundation Medicine in March 2021. He previously served as the company’s Chief Medical Officer, and practiced radiation oncology specializing in neuro-oncology at Dana-Farber Brigham Cancer Center. He is also a Senior [...]

Dr. Eliav Barr became head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), in April 2022. Previously he was Senior Vice President, Global Clinical Development and he has held positions of increasing responsibility including leadership roles in oncology and [...]

Jean-Charles Soria is Amgen’s Senior Vice President of Oncology within Global Development. Soria joined Amgen from Institut Gustave Roussy, where he was appointed director general by France’s Minister of Health and Solidarity. Soria is a medical oncologist and professor of medicine [...]